Latest news with #EverSunshine
Yahoo
08-07-2025
- Business
- Yahoo
Asian Penny Stocks: SSY Group And 2 Promising Contenders
As global markets continue to capture attention with mixed performances across major indices, investors are increasingly looking toward Asia for opportunities in smaller-cap stocks. Penny stocks, despite their somewhat outdated moniker, remain a relevant area of interest for those seeking potential value in less-established companies. By focusing on those with robust financials and clear growth prospects, these stocks can offer a compelling mix of stability and upside potential. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.25 HK$788.69M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$2.06 HK$3.56B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.28 HK$1.9B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.44 SGD178.33M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.14 HK$1.9B ★★★★★★ T.A.C. Consumer (SET:TACC) THB4.44 THB2.66B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.24 SGD8.82B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.205 SGD41.45M ★★★★★★ BRC Asia (SGX:BEC) SGD3.13 SGD858.72M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.55 HK$52.2B ★★★★★★ Click here to see the full list of 986 stocks from our Asian Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: SSY Group Limited is an investment holding company involved in the research, development, manufacturing, trading, and sale of pharmaceutical products to hospitals and distributors both in the People's Republic of China and internationally, with a market cap of HK$8.36 billion. Operations: The company generates revenue from two primary segments: Medical Materials, contributing HK$405.07 million, and Intravenous Infusion Solution and Others, which brings in HK$5.59 billion. Market Cap: HK$8.36B SSY Group Limited presents a complex picture for investors interested in penny stocks. The company has a satisfactory net debt to equity ratio of 29.6% and its short-term assets exceed both short-term and long-term liabilities, indicating solid liquidity. However, the company's earnings have experienced negative growth over the past year, contrasting with its 11.1% annual profit growth over five years. Recent approvals for several pharmaceutical products could enhance future revenue streams, yet the dividend yield of 6.16% is not well covered by free cash flows. Additionally, SSY's ongoing share repurchase program may positively impact earnings per share. Click here and access our complete financial health analysis report to understand the dynamics of SSY Group. Assess SSY Group's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Jinhai Medical Technology Limited is an investment holding company offering minimally invasive surgery solutions, medical products, and related services in China and Singapore, with a market cap of HK$7.60 billion. Operations: The company generates revenue from two main segments: Products, contributing SGD 25.93 million, and Services, accounting for SGD 24.31 million. Market Cap: HK$7.6B Jinhai Medical Technology Limited, while positioned in the minimally invasive surgery market, presents a mixed outlook for penny stock investors. The company exhibits strong liquidity with short-term assets of SGD 30.2 million exceeding both short and long-term liabilities. However, it remains unprofitable with losses escalating at an annual rate of 83.6% over five years and a negative return on equity of -55.69%. Despite having more cash than total debt and a cash runway exceeding three years, its increased debt-to-equity ratio from 0% to 32.9% raises concerns about financial stability amidst declining earnings. Click to explore a detailed breakdown of our findings in Jinhai Medical Technology's financial health report. Understand Jinhai Medical Technology's track record by examining our performance history report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Sinopec Shanghai Petrochemical Company Limited, along with its subsidiaries, is engaged in the manufacturing and sale of petroleum and chemical products in China, with a market cap of HK$27.40 billion. Operations: Sinopec Shanghai Petrochemical Company Limited does not report specific revenue segments. Market Cap: HK$27.4B Sinopec Shanghai Petrochemical Company Limited offers a complex picture for penny stock investors. Despite its substantial market cap of HK$27.40 billion and recent profitability, the company faces challenges with a low return on equity at 0.6%. Its financial health is supported by short-term assets of CN¥20.5 billion exceeding both short and long-term liabilities, and debt levels are well managed with more cash than total debt. Recent strategic moves include a steam sales contract with Baling New Materials to optimize resource use, alongside dividend affirmations and completed share buybacks, signaling shareholder value focus amidst fluctuating earnings performance. Navigate through the intricacies of Sinopec Shanghai Petrochemical with our comprehensive balance sheet health report here. Explore Sinopec Shanghai Petrochemical's analyst forecasts in our growth report. Navigate through the entire inventory of 986 Asian Penny Stocks here. Looking For Alternative Opportunities? These 14 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2005 SEHK:2225 and SEHK:338. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-07-2025
- Business
- Yahoo
Asian Penny Stocks Spotlight: Shengjing Bank And Two Others
As global markets continue to react positively to easing trade tensions and economic developments, investors are exploring diverse opportunities across regions. Penny stocks, though an older term, still capture the essence of investing in smaller or newer companies that may offer significant value at lower price points. By focusing on those with strong financials and growth potential, investors can uncover hidden gems within the Asian market landscape. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.24 HK$782.38M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$2.08 HK$3.6B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.27 HK$1.89B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.13 HK$1.89B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.24 SGD8.82B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.205 SGD41.45M ★★★★★★ BRC Asia (SGX:BEC) SGD3.10 SGD850.49M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.54 HK$52.01B ★★★★★★ United Energy Group (SEHK:467) HK$0.54 HK$13.96B ★★★★★★ Click here to see the full list of 997 stocks from our Asian Penny Stocks screener. Let's uncover some gems from our specialized screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Shengjing Bank Co., Ltd. and its subsidiaries provide banking products and financial services in Mainland China, with a market cap of HK$11.17 billion. Operations: The company generates revenue through three main segments: Retail Banking with CN¥1.87 billion, Corporate Banking at CN¥4.67 billion, and Treasury Business contributing CN¥176.56 million. Market Cap: HK$11.17B Shengjing Bank, with a market cap of HK$11.17 billion, operates through Retail Banking (CN¥1.87 billion), Corporate Banking (CN¥4.67 billion), and Treasury Business (CN¥176.56 million). Despite its high-quality earnings and appropriate loan levels, the bank faces challenges with declining profits—down 50% annually over five years—and low return on equity at 0.8%. The management team is experienced but the board lacks tenure depth, reflecting recent changes including Mr. Wang Jun's resignation due to retirement age and upcoming elections for new directors amid restructuring plans for village banks into branches. Click to explore a detailed breakdown of our findings in Shengjing Bank's financial health report. Gain insights into Shengjing Bank's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Guoquan Food (Shanghai) Co., Ltd. operates as a home meal products company in Mainland China with a market cap of HK$8.81 billion. Operations: The company generates revenue primarily from its Retail - Grocery Stores segment, amounting to CN¥6.47 billion. Market Cap: HK$8.81B Guoquan Food (Shanghai), with a market cap of HK$8.81 billion, is expanding its footprint by investing approximately RMB 490 million in a new production base in Hainan Province. Despite negative earnings growth last year and a low return on equity of 7.4%, the company maintains strong financial health with short-term assets exceeding liabilities and more cash than total debt. Recent strategic moves include increasing dividends and appointing Ms. Yang Tongyu as an executive director, reflecting efforts to enhance shareholder value and governance amidst stable weekly volatility at 11%. Earnings are projected to grow by 21.92% annually. Unlock comprehensive insights into our analysis of Guoquan Food (Shanghai) stock in this financial health report. Assess Guoquan Food (Shanghai)'s future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: United Energy Group Limited is an investment holding company involved in upstream oil, natural gas, clean energy, and energy trading operations across Pakistan, South Asia, the Middle East, and North Africa with a market cap of approximately HK$13.96 billion. Operations: The company generates revenue through two primary segments: Trading, which contributes HK$7.66 billion, and Exploration and Production, accounting for HK$9.86 billion. Market Cap: HK$13.96B United Energy Group, with a market cap of HK$13.96 billion, has shown resilience by becoming profitable this year despite a large one-off loss of HK$442.4 million impacting its recent financial results. The company generates substantial revenue from its Trading and Exploration and Production segments, totaling over HK$17 billion combined. While the company's debt is well-covered by operating cash flow, recent leadership changes highlight an evolving governance structure with new appointments in key roles. Despite high share price volatility and significant insider selling recently, United Energy Group trades at a good value compared to industry peers. Click here to discover the nuances of United Energy Group with our detailed analytical financial health report. Review our growth performance report to gain insights into United Energy Group's future. Jump into our full catalog of 997 Asian Penny Stocks here. Contemplating Other Strategies? Outshine the giants: these 22 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2066 SEHK:2517 and SEHK:467. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-07-2025
- Business
- Yahoo
Asian Penny Stocks: LX Technology Group Leads 3 Compelling Picks
As global markets experience a resurgence, with notable developments such as the new trade deal between the U.S. and China, investor sentiment is buoyed by optimism across major indices. Amidst this backdrop, penny stocks in Asia emerge as intriguing prospects for those seeking opportunities beyond traditional blue-chip investments. While often associated with smaller or newer companies, these stocks can present underappreciated growth potential when backed by solid financials and robust fundamentals. In this article, we explore three Asian penny stocks that stand out for their resilience and potential to offer significant returns. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.29 HK$813.93M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$2.04 HK$3.53B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.27 HK$1.89B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.435 SGD176.3M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.05 HK$1.75B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.25 SGD8.86B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.182 SGD36.26M ★★★★★★ BRC Asia (SGX:BEC) SGD3.12 SGD855.97M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.64 HK$53.16B ★★★★★★ United Energy Group (SEHK:467) HK$0.52 HK$13.44B ★★★★★★ Click here to see the full list of 1,001 stocks from our Asian Penny Stocks screener. We'll examine a selection from our screener results. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: LX Technology Group Limited offers device lifecycle management solutions in the People's Republic of China and Hong Kong, with a market capitalization of approximately HK$1.02 billion. Operations: The company's revenue is derived from three main segments: Device Recycling (CN¥1.84 billion), Device Subscription (CN¥379.48 million), and IT Technical Subscription (CN¥156.55 million). Market Cap: HK$1.02B LX Technology Group Limited, with a market capitalization of HK$1.02 billion, derives significant revenue from device lifecycle management solutions in China and Hong Kong. Despite being unprofitable, the company has reduced its losses by 19.8% annually over the past five years and maintains a seasoned management team with an average tenure of 6.2 years. The company's short-term assets exceed both short- and long-term liabilities, indicating solid liquidity. However, it faces high volatility in share price and a net debt to equity ratio of 56.8%. Shareholders have not experienced meaningful dilution recently, reflecting stability in ownership structure. Dive into the specifics of LX Technology Group here with our thorough balance sheet health report. Examine LX Technology Group's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★★ Overview: PropNex Limited is an investment holding company that offers real estate services in Singapore, with a market capitalization of SGD 814 million. Operations: The company's revenue is primarily derived from Agency Services at SGD 591.61 million and Project Marketing Services at SGD 185.57 million, with additional contributions from Training Services at SGD 3.48 million and Administrative Support Services at SGD 2.29 million. Market Cap: SGD814M PropNex Limited, with a market cap of SGD 814 million, has shown mixed performance as a penny stock. Despite being debt-free and having high-quality earnings, the company faces challenges such as negative earnings growth over the past year and unsustainable dividend coverage. Its net profit margin has declined slightly to 5.2%, and management is relatively inexperienced with an average tenure of 1.9 years. However, PropNex maintains strong liquidity with short-term assets exceeding liabilities and offers a high return on equity at 33.4%. The stock trades significantly below estimated fair value, presenting potential opportunities for investors mindful of its volatility and recent financial performance trends. Click here to discover the nuances of PropNex with our detailed analytical financial health report. Evaluate PropNex's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Quzhou Xin'an Development Co., Ltd. operates in real estate development, technology manufacturing, and financial services in China with a market cap of CN¥24.32 billion. Operations: The company generates CN¥14.59 billion in revenue from its operations in China. Market Cap: CN¥24.32B Quzhou Xin'an Development, with a market cap of CN¥24.32 billion, presents a complex picture for potential investors. The company's revenue has dropped significantly to CN¥344.89 million from CN¥2.24 billion year-on-year, yet net income rose to CN¥423.95 million, indicating improved profit margins of 7.3%. Despite high debt levels and low return on equity at 4.5%, the company maintains strong short-term asset coverage over liabilities and has reduced its debt-to-equity ratio over five years. Trading at good value relative to peers, it offers high-quality earnings but faces challenges with negative recent earnings growth and limited operating cash flow coverage for its debt obligations. Click to explore a detailed breakdown of our findings in Quzhou Xin'an Development's financial health report. Assess Quzhou Xin'an Development's future earnings estimates with our detailed growth reports. Unlock our comprehensive list of 1,001 Asian Penny Stocks by clicking here. Searching for a Fresh Perspective? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 22 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2436 SGX:OYY and SHSE:600208. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
07-07-2025
- Business
- Yahoo
3 Asian Penny Stocks With Market Caps Over US$900M
As global markets navigate a complex landscape with mixed economic signals, investors are increasingly looking toward diverse opportunities to balance their portfolios. Penny stocks, though often associated with high risk and volatility, continue to attract attention for their potential value and growth prospects when backed by strong fundamentals. In this article, we explore three Asian penny stocks that stand out due to their financial strength and promising outlooks, offering intriguing possibilities for those seeking under-the-radar investments in the region. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.29 HK$813.93M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$2.08 HK$3.6B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.28 HK$1.9B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.14 HK$1.9B ★★★★★★ T.A.C. Consumer (SET:TACC) THB4.42 THB2.65B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.92 THB1.35B ★★★★★★ Beng Kuang Marine (SGX:BEZ) SGD0.20 SGD40.44M ★★★★★★ BRC Asia (SGX:BEC) SGD3.16 SGD866.95M ★★★★★★ Click here to see the full list of 993 stocks from our Asian Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Viva Goods Company Limited is an investment holding company that supplies apparel and footwear across various regions including the UK, Ireland, US, China, Asia, Europe, the Middle East, and Africa with a market cap of HK$4.43 billion. Operations: The company generates revenue from two primary segments: Sports Experience, contributing HK$559.30 million, and Multi-Brand Apparel and Footwear, which accounts for HK$9.87 billion. Market Cap: HK$4.43B Viva Goods Company Limited, with a market cap of HK$4.43 billion, operates in the apparel and footwear sectors across multiple regions. Despite generating significant revenue from its Multi-Brand Apparel and Footwear segment (HK$9.87 billion), the company remains unprofitable with increasing losses over five years. The recent appointment of Victor Herrero as Co-CEO may bring strategic leadership given his extensive industry experience. Viva Goods' financial stability is supported by short-term assets exceeding liabilities and debt well-covered by operating cash flow, although profitability challenges persist. A share repurchase program aims to enhance shareholder value amidst stable weekly volatility in stock performance. Take a closer look at Viva Goods' potential here in our financial health report. Gain insights into Viva Goods' historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: The Hour Glass Limited is an investment holding company that operates in the retailing and distribution of watches, jewelry, and other luxury products across various countries including Singapore, Hong Kong, Japan, and more; it has a market cap of SGD1.25 billion. Operations: The company's revenue is primarily derived from its operations in the retailing and distribution of watches, jewelry, and other luxury products, amounting to SGD1.17 billion. Market Cap: SGD1.25B The Hour Glass Limited, with a market cap of SGD1.25 billion, shows financial resilience despite recent earnings decline. The company reported revenue of SGD1.18 billion for the year ended March 2025, reflecting growth from the previous year. Its net income decreased to SGD135.81 million, impacting profit margins slightly lower than last year's figures. The management team and board have seasoned tenures averaging 4.8 and 8.3 years respectively, contributing to strategic stability amidst volatile earnings in the specialty retail industry. Strong liquidity is evident as short-term assets significantly exceed liabilities and debt levels are well-managed by cash flow operations. Unlock comprehensive insights into our analysis of Hour Glass stock in this financial health report. Understand Hour Glass' track record by examining our performance history report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Lecron Industrial Development Group Co., Ltd. (SZSE:300343) operates in the industrial sector with a market cap of CN¥5.06 billion. Operations: Lecron Industrial Development Group Co., Ltd. (SZSE:300343) currently does not report distinct revenue segments. Market Cap: CN¥5.06B Lecron Industrial Development Group, with a market cap of CN¥5.06 billion, has shown financial improvement by becoming profitable over the past year. The company reported first-quarter sales of CN¥160.57 million and net income of CN¥5.02 million, reversing a previous loss. Despite this progress, its Return on Equity remains low at 2.1%. The management team is experienced with an average tenure of 8.9 years, and the board authorized a share repurchase program worth up to CN¥100 million to enhance shareholder value through equity incentives or ESOP implementation over the next year. Navigate through the intricacies of Lecron Industrial Development Group with our comprehensive balance sheet health report here. Assess Lecron Industrial Development Group's previous results with our detailed historical performance reports. Reveal the 993 hidden gems among our Asian Penny Stocks screener with a single click here. Ready For A Different Approach? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 22 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:933 SGX:AGS and SZSE:300343. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
07-07-2025
- Business
- Yahoo
Asian Penny Stocks To Monitor In July 2025
As global markets experience varied performances, with the U.S. indices hitting record highs and Japan facing trade negotiation challenges, investors are keenly observing the shifting dynamics in Asia. Amidst these developments, penny stocks—traditionally smaller or newer companies—continue to capture attention for their potential value and growth opportunities. While the term may seem outdated, these stocks still hold relevance as they often represent companies with solid financial foundations that could offer stability and potential upside in a fluctuating market landscape. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.29 HK$813.93M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$2.08 HK$3.6B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.28 HK$1.9B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.14 HK$1.9B ★★★★★★ T.A.C. Consumer (SET:TACC) THB4.42 THB2.65B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.92 THB1.35B ★★★★★★ Beng Kuang Marine (SGX:BEZ) SGD0.20 SGD40.44M ★★★★★★ BRC Asia (SGX:BEC) SGD3.16 SGD866.95M ★★★★★★ Click here to see the full list of 993 stocks from our Asian Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★★★ Overview: PSG Corporation Public Company Limited, with a market cap of THB14.79 billion, operates in turnkey engineering, procurement, and construction (EPC) and large-scale construction projects in Thailand and the Lao People's Democratic Republic. Operations: The company's revenue is primarily derived from its plant and building construction segment, amounting to THB2.82 billion. Market Cap: THB14.79B PSG Corporation, with a market cap of THB14.79 billion, operates in the EPC and construction sectors in Thailand and Laos. Despite being debt-free and having short-term assets significantly exceeding liabilities, PSG's earnings have declined substantially over the past year, with revenue dropping to THB642.96 million from THB1.49 billion a year ago. The company's net profit margin has also decreased from 51.6% to 26.8%. Recent volatility in share price could be attributed to these financial results and strategic moves like the recent MOU with Electricite du Laos for renewable energy projects, potentially enhancing future growth prospects amidst current challenges. Navigate through the intricacies of PSG Corporation with our comprehensive balance sheet health report here. Evaluate PSG Corporation's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: CSE Global Limited is an investment holding company that provides integrated industrial automation, information technology, and intelligent transport solutions across the Asia Pacific, the Americas, Europe, the Middle East, and Africa with a market cap of SGD436.54 million. Operations: The company's revenue is derived from three primary segments: Automation (SGD194.36 million), Communications (SGD232.04 million), and Electrification (SGD434.78 million). Market Cap: SGD436.54M CSE Global Limited, with a market cap of SGD436.54 million, shows a stable financial foundation with short-term assets exceeding liabilities and well-covered interest payments by EBIT. Despite experiencing a 5.4% annual decline in earnings over the past five years, recent profit growth of 16.9% signals potential recovery, outpacing industry averages. The company's seasoned management and board add strategic depth, further enhanced by the recent appointment of Mr. Ravinder Singh as Non-Executive Director to bolster governance capabilities. However, dividend sustainability remains questionable due to insufficient free cash flow coverage despite trading below estimated fair value. Click here to discover the nuances of CSE Global with our detailed analytical financial health report. Assess CSE Global's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang CONBA Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of pharmaceuticals and health products in mainland China, with a market cap of CN¥11.27 billion. Operations: The company's revenue primarily comes from its operations in China, totaling CN¥6.38 billion. Market Cap: CN¥11.27B Zhejiang CONBA Pharmaceutical Co., Ltd. demonstrates a solid financial position with short-term assets of CN¥4.5 billion surpassing both short and long-term liabilities, and its debt is well-covered by operating cash flow. Despite a slight decline in quarterly revenue to CN¥1.68 billion, the company maintains profitability with net income at CN¥189.4 million and improved profit margins from 8.1% to 9.3%. However, its return on equity remains low at 8.7%, and the board's average tenure suggests inexperience, potentially impacting strategic decisions amidst an unstable dividend track record despite trading below estimated fair value by 16.6%. Dive into the specifics of Zhejiang CONBA PharmaceuticalLtd here with our thorough balance sheet health report. Examine Zhejiang CONBA PharmaceuticalLtd's past performance report to understand how it has performed in prior years. Navigate through the entire inventory of 993 Asian Penny Stocks here. Want To Explore Some Alternatives? We've found 16 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SET:PSG SGX:544 and SHSE:600572. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
